Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-31 | New | $99,999 | $99,999 | Equity Only | 06b | SEC link |
| 2022-06-16 | New | $205,501 | $205,501 | Equity Only | 06b | SEC link |
| 2020-09-10 | New | $1,020,000 | $1,020,000 | Equity Only | 06b | SEC link |
| 2016-09-16 | New | $739,500 | $739,500 | Equity Only | 06b | SEC link |
| 2016-03-02 | New | $325,000 | $325,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Todd Beck | Director, Executive, Promoter |
| David Bowman | Executive |
| Paul Burton | Director, Executive |
| Steve Bylina | Director, Executive, Promoter |
| Antoinette Gawin | Director, Executive, Promoter |
| Paul Hertz | Director, Executive, Promoter |
| Dominic O'keefe | Director, Executive, Promoter |
| Israel Rubinstein | Director |
| August H. Schupp | Director, Executive, Promoter |
| Joel Tune | Director, Executive, Promoter |
| Guy Weinberg | Director, Executive, Promoter |
| Francis Wisniewski | Director, Executive, Promoter |